SEPT7 Antibody

What is SEPT7 and why is it important in cellular research?

SEPT7 is a member of the septin family of GTPases that forms heteromeric complexes essential for various cellular functions. It plays pivotal roles in cytokinesis, particularly in fibroblasts where it is indispensable for cell division . In neuronal tissue, SEPT7 contributes to developmental processes and has been implicated in multiple neurological conditions. Research has revealed that SEPT7 interacts with cytoskeletal elements and participates in membrane organization, making it a significant target for studies investigating cellular architecture and function .

What applications are SEPT7 antibodies typically used for in research?

SEPT7 antibodies are utilized across multiple experimental platforms including Western blotting (WB), immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) . The versatility of these antibodies enables visualization of SEPT7 localization within cells and tissues, quantification of expression levels, and investigation of protein-protein interactions through co-immunoprecipitation studies . The breadth of applications supports comprehensive research from protein expression analysis to functional studies in various model systems.

What species reactivity should be considered when selecting a SEPT7 antibody?

Most commercially available SEPT7 antibodies demonstrate reactivity across multiple mammalian species. Based on validation data, researchers should select antibodies with confirmed reactivity to their experimental model. Many SEPT7 antibodies show cross-reactivity with human, mouse, and rat SEPT7 proteins due to high sequence conservation . Some antibodies may have predicted reactivity with additional species such as pig, bovine, horse, sheep, rabbit, dog, chicken, and Xenopus . Researchers should verify species reactivity through literature or preliminary testing when working with less common experimental models.

How should dilution ratios be optimized for different SEPT7 antibody applications?

Dilution optimization is essential for balancing signal intensity with background noise. Starting dilution recommendations vary by application: for Western blotting, begin with 1:500-1:2000; for immunohistochemistry, 1:50-1:300; for ELISA, 1:20000; and for immunocytochemistry/immunofluorescence, 1:50-1:200 . These ranges provide initial guidance, but researchers should perform dilution series to determine optimal concentrations for their specific experimental conditions, antibody lot, and sample type. Titration experiments are particularly important when using new antibody lots or when changing experimental parameters such as fixation methods or detection systems.

What molecular weight should be observed for SEPT7 in Western blot analysis?

SEPT7 typically appears at approximately 50-52 kDa based on amino acid sequence, but the observed molecular weight on Western blots is often higher at approximately 72 kDa . This discrepancy between calculated and observed molecular weights (50680 Da vs. 72 kDa) may result from post-translational modifications, particularly phosphorylation, as evidenced by research identifying phosphorylation-dependent interactions with 14-3-3 proteins . When performing Western blot analysis, researchers should verify band specificity using appropriate controls such as SEPT7 knockout samples or blocking peptides, as demonstrated in validation studies where lysates from HeLa, HUVEC, and MCF-7 cells showed specific bands that were blocked by synthesized peptide .

What are the recommended storage and handling conditions for SEPT7 antibodies?

For optimal antibody performance and longevity, store SEPT7 antibodies at -20°C for long-term storage (up to one year). For frequent use over shorter periods (up to one month), storage at 4°C is acceptable . Most commercial SEPT7 antibodies are supplied in a buffer containing PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide as preservative . Repeated freeze-thaw cycles significantly diminish antibody activity and should be avoided by aliquoting the antibody before freezing. When working with the antibody, maintain cold chain practices and handle the antibody according to laboratory safety guidelines, particularly noting the presence of sodium azide, which is toxic and can form explosive compounds in metal drain pipes.

How can phospho-specific SEPT7 antibodies be utilized to study its regulation?

Phospho-specific antibodies targeting SEPT7, such as the pT426 antibody, are valuable tools for investigating post-translational regulation of SEPT7 function. These antibodies enable detection of phosphorylated SEPT7 in co-immunoprecipitation experiments to identify phosphorylation-dependent protein interactions, as demonstrated in studies of 14-3-3 protein binding to phosphorylated SEPT7 . When using phospho-specific antibodies, researchers should include appropriate controls such as phosphatase treatment to confirm specificity. These antibodies are particularly useful in signaling pathway studies to determine how cellular stimuli affect SEPT7 phosphorylation status and subsequent protein interactions or localization patterns. For optimal results, researchers should maintain phosphatase inhibitors in their experimental buffers when studying phosphorylated SEPT7.

What approaches can address potential cross-reactivity with other septin family members?

Cross-reactivity with other septin family members presents a significant challenge due to high sequence homology. Researchers should select antibodies targeting unique regions of SEPT7, particularly the C-terminal domain which shows greater sequence divergence from other septins . Validation strategies include:

• Western blot comparison using recombinant septin proteins

• Immunodetection in SEPT7 knockout or knockdown models

• Peptide competition assays with specific SEPT7 peptides

• Mass spectrometry validation of immunoprecipitated proteins

When publishing research, clearly document the validation methods employed and acknowledge potential limitations. For studies requiring absolute specificity, consider using multiple antibodies targeting different epitopes or complementing antibody-based detection with genetic approaches.

How can SEPT7 antibodies be used in co-immunoprecipitation studies to identify interaction partners?

Co-immunoprecipitation (co-IP) with SEPT7 antibodies effectively identifies protein interaction networks. Research has successfully employed this approach to demonstrate interaction between phosphorylated SEPT7 and 14-3-3 proteins in neuronal development studies . For successful co-IP experiments:

• Use antibodies validated for immunoprecipitation applications

• Optimize cell lysis conditions to preserve protein complexes (gentle detergents like NP-40 or Triton X-100)

• Include appropriate controls (IgG control, input samples)

• Consider crosslinking approaches for transient interactions

• Validate findings with reciprocal co-IP experiments

When investigating phosphorylation-dependent interactions, incorporate phosphatase inhibitors in lysis buffers and consider using phospho-specific antibodies like pT426 SEPT7 antibody . For protein complexes resistant to standard co-IP conditions, proximity labeling methods like BioID may provide complementary approaches.

How are SEPT7 antibodies utilized in neurological research?

SEPT7 antibodies have been instrumental in elucidating septin functions in neuronal development and pathology. In neuronal cultures, these antibodies enable visualization of SEPT7 distribution in developing neurons through immunofluorescence, revealing its roles in dendritic spine morphology and synaptic organization . For neurological tissue analysis, researchers employ SEPT7 antibodies in both fluorescence and chromogenic immunohistochemistry to map expression patterns across brain regions. Advanced applications include co-localization studies with synaptic markers and cytoskeletal components to determine SEPT7's contribution to neuronal architecture. Importantly, studies examining phosphorylation-dependent interactions with 14-3-3 proteins have utilized phospho-specific SEPT7 antibodies to elucidate regulatory mechanisms in neuronal development .

What is the significance of SEPT7 autoantibodies in neurological disorders?

Research has identified SEPT7-targeting autoantibodies (SEPT7-IgG) in patients with various neurological conditions, highlighting potential autoimmune mechanisms in these disorders . Clinical studies have demonstrated SEPT7-IgG presence in patients with encephalopathy, myelopathy, and episodic ataxia, with notable psychiatric manifestations including agitation, apathy, catatonia, disorganized thinking, and paranoia in some cases . Detection methods include indirect immunofluorescence assays using mouse tissue, cell-based assays, and western blotting. For clinical research on SEPT7 autoimmunity, cerebral spinal fluid and serum samples should be collected before immunotherapy initiation to maximize detection sensitivity. The identification of these autoantibodies provides diagnostic biomarkers and insights into pathophysiological mechanisms, suggesting potential autoimmune contributions to neuropsychiatric conditions previously considered idiopathic.

How can SEPT7 antibodies be used to investigate its role in cell division and cancer research?

SEPT7's critical role in cytokinesis, particularly in fibroblasts, makes it relevant to cancer research where dysregulated cell division is fundamental . Researchers can employ SEPT7 antibodies to:

• Assess SEPT7 expression levels across tumor types through immunohistochemistry and Western blotting

• Visualize SEPT7 localization during mitosis using immunofluorescence microscopy

• Investigate interaction with other cytokinetic components through co-immunoprecipitation

• Evaluate SEPT7 as a potential prognostic marker through tissue microarray studies

When conducting cancer-related SEPT7 research, consider complementing antibody-based approaches with genetic manipulation models. Conditional knockout systems, as described in genetic deletion studies, provide valuable tools for cell type-specific analysis of SEPT7 function . Flow cytometry protocols using SEPT7 antibodies combined with DNA content analysis can reveal cell cycle abnormalities in SEPT7-deficient cells, offering insights into its mechanistic contributions to cancer progression.

What protocols are recommended for flow cytometry analysis using SEPT7 antibodies?

For flow cytometric detection of SEPT7, researchers should follow a fixation and permeabilization protocol that preserves epitope accessibility. Based on validated methodologies, the following procedure is recommended:

• Fix cells with 4% paraformaldehyde at room temperature for 30 minutes

• Permeabilize with 90% methanol on ice for 30 minutes (critical for intracellular access)

• Block with 4% BSA in PBS at 4°C for 30 minutes

• Incubate with primary SEPT7 antibody (1:100 dilution in 1% BSA-PBS) at room temperature for 30 minutes

• Wash with PBS

• Incubate with fluorophore-conjugated secondary antibody (1:500 dilution) for 30 minutes

• Wash before analysis

For dual analysis of SEPT7 expression and DNA content, incorporate propidium iodide staining after antibody labeling, including RNase treatment to reduce background . When analyzing results, establish gating strategies based on negative controls and isotype controls to accurately identify SEPT7-positive populations.

How should researchers design experiments to study SEPT7 phosphorylation and its functional implications?

Investigating SEPT7 phosphorylation requires careful experimental design to capture this dynamic post-translational modification. Begin by selecting phospho-specific antibodies targeting key regulatory sites such as T426 . For phosphorylation studies:

• Incorporate phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in all lysis buffers

• Include phosphatase-treated controls to confirm antibody specificity

• Consider stimulation conditions that might regulate SEPT7 phosphorylation

• Employ Phos-tag gels for enhanced separation of phosphorylated species

To connect phosphorylation with function, combine phospho-detection with interaction studies. For example, research has shown that phosphorylated SEPT7 interacts with 14-3-3 proteins, particularly the gamma isoform, influencing neuronal development . Co-immunoprecipitation experiments using both standard and phospho-specific SEPT7 antibodies can reveal phosphorylation-dependent interactions. For comprehensive analysis, complement antibody-based approaches with phosphomimetic and phospho-null mutants in functional assays.

What considerations are important when using SEPT7 antibodies in various immunohistochemical applications?

Successful immunohistochemical detection of SEPT7 requires optimization of multiple parameters. For paraffin-embedded tissues, antigen retrieval is critical—Tris-EDTA buffer at pH 9.0 has been validated for SEPT7 detection . Antibody dilutions ranging from 1:50 to 1:300 are recommended as starting points, with overnight incubation at 4°C providing optimal results for many primary antibodies . Secondary antibody selection should consider the host species of the primary antibody (typically rabbit for most commercial SEPT7 antibodies) and the desired detection method (fluorescent or chromogenic).

For multiplex immunofluorescence applications, researchers should carefully select antibody combinations to avoid species cross-reactivity and spectral overlap. When comparing SEPT7 expression across experimental conditions or tissues, standardize all aspects of the protocol including fixation duration, antigen retrieval methods, blocking conditions, and development times. Validation controls should include known positive tissues (such as tonsil for human samples) and negative controls (primary antibody omission and ideally SEPT7-depleted tissues) . For quantitative analysis of immunohistochemical staining, establish consistent scoring methods and consider automated image analysis to reduce subjectivity.